NIAID Releases Emergency Funding Opportunities to Address COVID-19

On April 30, NIAID announced emergency awards (R21 and R01) to support research on SARS-CoV-2 and Coronavirus Disease 2019.

PAR-20-177, Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21, Clinical Trial Not Allowed)
PAR-20-178, Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01, Clinical Trial Not Allowed)